376
Views
0
CrossRef citations to date
0
Altmetric
Research Article

The Soluble Suppression of Tumorigenicity 2 as a Biomarker of Early Cardiac Remodeling in Bradycardia Patients Receiving Permanent Pacemaker Therapy

ORCID Icon, ORCID Icon, , , , & show all
Article: FSO831 | Received 04 Jan 2023, Accepted 15 Feb 2023, Published online: 03 Mar 2023

References

  • GliksonM , NielsenJC , KronborgMBet al.2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur. Heart J.42(35), 3427–3520 (2021).
  • KiehlEL , MakkiT , KumarRet al.Incidence and predictors of right ventricular pacing-induced cardiomyopathy in patients with complete atrioventricular block and preserved left ventricular systolic function. Heart Rhythm13(12), 2272–2278 (2016).
  • SweeneyMO , HellkampAS. Heart failure during cardiac pacing. Circulation113(17), 2082–2088 (2006).
  • GongX , SuY , PanWet al.Is right ventricular outflow tract pacing superior to right ventricular apex pacing in patients with normal cardiac function?Clin. Cardiol.32(12), 695–699 (2009).
  • VictorF , MaboP , MansourHet al.A randomized comparison of permanent septal versus apical right ventricular pacing: short-term results. J. Cardiovasc. Electrophysiol.17(3), 238–242 (2006).
  • KhurshidS , LiangJJ , OwensAet al.Longer paced QRS duration is associated with increased prevalence of right ventricular pacing-induced cardiomyopathy. J. Cardiovasc. Electrophysiol.27(10), 1174–1179 (2016).
  • KimJH , KangKW , ChinJYet al.Major determinant of the occurrence of pacing-induced cardiomyopathy in complete atrioventricular block: a multicentre, retrospective analysis over a 15-year period in South Korea. BMJ Open8(2), e019048 (2018).
  • XuH , XieX , LiJet al.Early right ventricular apical pacing-induced gene expression alterations are associated with deterioration of left ventricular systolic function. Dis. Markers2017, 8405196 (2017).
  • IqbalM , EndamatrizaGR , LampitaIet al.The influence of right ventricular pacing location, pacing burden and paced QRS duration to subclinical left ventricular systolic dysfunction as shown by global longitudinal strain echocardiography. Acta. Med. Indones.53(3), 245–253 (2021).
  • AzevedoPS , PolegatoBF , MinicucciMFet al.Cardiac remodeling: concepts, clinical impact, pathophysiological mechanisms and pharmacologic treatment. Arq. Bras. Cardiol.106(1), 62–69 (2016).
  • YancyCW , JessupM , BozkurtBet al.2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart Failure Society of America. Circulation136(6), e137–e161 (2017).
  • LotierzoM , DupuyAM , KalmanovichEet al.sST2 as a value-added biomarker in heart failure. Clin. Chim. Acta501, 120–130 (2020).
  • WeinbergEO , ShimpoM , HurwitzSet al.Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation107(5), 721–726 (2003).
  • SanadaS , HakunoD , HigginsLJet al.IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J. Clin. Invest.117(6), 1538–1549 (2007).
  • SarheneM , WangY , WeiJet al.Biomarkers in heart failure: the past, current and future. Heart Fail. Rev.24(6), 867–903 (2019).
  • ChiladakisJA , KoutsogiannisN , KalogeropoulosAet al.Permanent and atrial-synchronized ventricular stimulation for clinically stable patients with normal or impaired left ventricular systolic function. Pacing Clin. Electrophysiol.30(2), 182–187 (2007).
  • SweeneyMO , HellkampAS , LeeKLet al.Association of prolonged QRS duration with death in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation111(19), 2418–2423 (2005).
  • ZhangXH , ChenH , SiuCWet al.New-onset heart failure after permanent right ventricular apical pacing in patients with acquired high-grade atrioventricular block and normal left ventricular function. J. Cardiovasc. Electrophysiol.19(2), 136–141 (2008).
  • BleekerGB , BaxJJ , SteendijkPet al.Left ventricular dyssynchrony in patients with heart failure: pathophysiology, diagnosis and treatment. Nat. Clin. Pract. Cardiovasc. Med.3(4), 213–219 (2006).
  • SharmaG , ShetkarSS , PatelCDet al.Paced QRS duration predicts left ventricular function in patients with permanent pacemakers – One-year follow-up study using equilibrium radionuclide angiography (ERNA). Indian Pacing Electrophysiol. J.15(2), 90–95 (2015).
  • MiyoshiF , KobayashiY , ItouHet al.Prolonged paced QRS duration as a predictor for congestive heart failure in patients with right ventricular apical pacing. Pacing Clin. Electrophysiol.28(11), 1182–1188 (2005).
  • BansalR , ParakhN , GuptaAet al.Incidence and predictors of pacemaker-induced cardiomyopathy with comparison between apical and non-apical right ventricular pacing sites. J. Interv. Card. Electrophysiol.56(1), 63–70 (2019).
  • AbdinA , YalinK , ZinkMDet al.Incidence and predictors of pacemaker induced cardiomyopathy: a single-center experience. J. Electrocardiol.57, 31–34 (2019).
  • SobieszekG , PowrózekT , JaroszyńskiAet al.Soluble ST2 proteins in male cachectic patients with chronic heart failure. Nutr. Metab. Cardiovasc. Dis.31(3), 886–893 (2021).
  • MiticVT , StojanovicDR , DeljaninIlic MZet al.Cardiac remodeling biomarkers as potential circulating markers of left ventricular hypertrophy in heart failure with preserved ejection fraction. Tohoku J. Exp. Med.250(4), 233–242 (2020).
  • HeidenreichPA , BozkurtB , AguilarDet al.2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation79(17), 1757–1780 (2022).